🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

FDNA will be at the American Society of Human Genetics (ASHG) 2024 meeting in Denver, CO, November 5-9! Come learn how you can expedite and simplify the diagnostic process, including AI tools for patient intake. #ASHG24 #Genetics #AI #FDNA #Face2Gene

FDNA is excited to be part of the #ASHG2024 Annual Meeting! Visit our booth (884) to learn more about how our innovative facial analysis technologies and AI solutions empower clinicians around the globe to expedite and simplify the diagnostic process.

Honored to have hosted  Dr. Aimé Lumaka and Dr. Gerrye Mubungu at our booth during #ASHG2024! Their dedication to advancing genetic research and phenotyping in Africa inspires our global mission.

Why is phenotyping in Africa so critical for the future of genetic research? Dr. AIME LUMAKA shares his insights in this exclusive interview, highlighting the challenges, breakthroughs, and importance of diversity in genetic datasets. fdna.com/blog/genetic-r…

This Rare Disease Day, we stand with the global community—patients, doctors, and advocates—united in one goal: a future where no one is undiagnosed, and every family finds hope. #RareDiseaseDay #LightUpForRare #FDNA

Check out the interview with Aviram Bar-Haim, a key engineer in Face2Gene’s development who shares how FDNA's technology has advanced, the challenges tackled, and what’s next for AI-driven phenotyping. fdna.com/blog/the-evolu…

FDNA is heading to Los Angeles for the ACMG - American College of Medical Genetics and Genomics 2025 meeting. Our team is focused on reducing waiting lists and helping more qualified patients access the care they need through innovative technology.

Hey #ACMG2025! Swing by the #FDNA booth #919 today! We've got cool tech, great chats, and a team ready to talk all about AI in genetics. Come say hi! #FDNA #AIinGenetics #PrecisionMedicine

Dr. Karen Gripp is moderating the session 'Fetal Fentanyl Syndrome — A Teratogen-Induced Embryopathy Masquerading as a Metabolic Disease' at #ACMG2025. Important discussions on this emerging condition! #Face2Gene #Genetics

Erin Wadman is discussing the identification of Fetal Fentanyl Syndrome at #ACMG2025. Shared prenatal history of opioid use disorder with known fentanyl use throughout pregnancy emerged as a potential cause of this novel condition. #Face2Gene #Genetics

A key aspect of the study was the distinctive facial features shared by affected children. Sarah Savage presents how Face2Gene's GestaltMatcher technology was used to objectively assess these features at #ACMG2025. #Genetics

In the world of rare genetic diseases, early diagnosis is often the key to better patient outcomes. Dr. Bruno Bordest has been working to bridge this gap by introducing #Face2Gene to pediatricians and general practitioners: fdna.com/blog/the-impor…

A long journey led Annette to her son’s diagnosis: KBG syndrome. Now, through the KBG Foundation, she's helping other families get answers sooner. We're proud to partner with the Foundation to support earlier recognition of KBG. #RareDisease #Face2Gene #KBGFoundation #Genetics

New American Academy of Pediatrics guidance now recommends #PhenotypeFirst testing for children with GDD/ID, affecting up to 3% of kids. This shift empowers PCPs in earlier rare disease detection. @FDNA has championed this for years - now it’s standard of care! 🔗 bit.ly/4k8w6We